These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 11575892)

  • 41. Comparative efficacy of terbutaline sulphate delivered by Turbuhaler dry powder inhaler or pressurised metered dose inhaler with Nebuhaler spacer in children during an acute asthmatic episode.
    Drblik S; Lapierre G; Thivierge R; Turgeon J; Gaudreault P; Cummins-McManus B; Verdy I; Haddon J; Lee J; Spier S
    Arch Dis Child; 2003 Apr; 88(4):319-23. PubMed ID: 12651757
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Airmax: a multi-dose dry powder inhaler.
    Keating GM; Faulds D
    Drugs; 2002; 62(13):1887-95; discussion 1896-7. PubMed ID: 12215059
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The importance of the device in asthma therapy.
    Borgström L
    Respir Med; 2001 Aug; 95 Suppl B():S26-9. PubMed ID: 11534894
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Salbutamol via Easyhaler is at least as effective as salbutamol via Turbuhaler in the treatment of histamine-induced bronchoconstriction.
    Zetterström O; Lähelmä S; Keski-karhu J; Silvasti M; Ostling-kulling E; Ahonen A
    Respir Med; 2000 Nov; 94(11):1097-102. PubMed ID: 11127498
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The safety and efficacy of formoterol (Oxis) turbuhaler plus budesonide (Pulmicort) turbuhaler in mild to moderate asthma: a comparison with budesonide Turbuhaler alone and current non-corticosteroid therapy in Russia.
    Chuchalin AG; Ovcharenko SI; Goriachkina LA; Sidorenko IV; Tsoi AN;
    Int J Clin Pract; 2002; 56(1):15-20. PubMed ID: 11833550
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical comparisons of inhaler systems: what are the important aspects?
    O'Byrne PM
    J Aerosol Med; 1995 Sep; 8 Suppl 3():S39-46; discussion S47. PubMed ID: 10157898
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Patient-reported outcomes in adults with moderate to severe asthma after use of budesonide and formoterol administered via 1 pressurized metered-dose inhaler.
    Chervinsky P; Baker J; Bensch G; Parasuraman B; Boggs R; Martin P; O'Dowd L
    Ann Allergy Asthma Immunol; 2008 Nov; 101(5):463-73. PubMed ID: 19055199
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A health-related quality-of-life comparison of formoterol (Oxis) Turbuhaler plus budesonide (Pulmicort) Turbuhaler with budesonide Turbuhaler alone and noncorticosteroid treatment in asthma: a randomized clinical study in Russia.
    Chuchalin AG; Svensson K; Ståhl E; Ovcharenko SI; Goriachkina LA; Sidorenko IV; Tsoi AN;
    Respiration; 2002; 69(5):427-33. PubMed ID: 12232450
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Dose-related efficacy of budesonide administered via a dry powder inhaler in the treatment of children with moderate to severe persistent asthma.
    Shapiro G; Bronsky EA; LaForce CF; Mendelson L; Pearlman D; Schwartz RH; Szefler SJ
    J Pediatr; 1998 Jun; 132(6):976-82. PubMed ID: 9627589
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Beclomethasone dipropionate Easyhaler is as effective as budesonide Turbohaler in the control of asthma and is preferred by patients. German Study Group.
    Jäger L; Laurikainen K; Leinonen M; Silvasti M
    Int J Clin Pract; 2000; 54(6):368-72. PubMed ID: 11092110
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical efficacy and safety of budesonide Turbuhaler in adults.
    Hultquist C
    J Aerosol Med; 1994; 7(Suppl 1):S63-6. PubMed ID: 10147082
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Gamma scintigraphic evaluation of a novel budesonide dry powder inhaler using a validated radiolabeling technique.
    Warren S; Taylor G; Smith J; Buck H; Parry-Billings M
    J Aerosol Med; 2002; 15(1):15-25. PubMed ID: 12006142
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Double-blind, double-dummy, multinational, multicenter, parallel-group design clinical trial of clinical non-inferiority of formoterol 12 microg/unit dose in a b.i.d. regimen administered via an HFA-propellant-pMDI or a dry powder inhaler in a 12-week treatment period of moderate to severe stable persistent asthma in adult patients.
    Dusser D; Vicaut E; Lefrançois G;
    Respiration; 2005; 72 Suppl 1():20-7. PubMed ID: 15915009
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Budesonide Turbuhaler delivered once daily improves health-related quality of life and maintains improvements with a stepped-down dose in adults with mild to moderate asthma.
    Casale TB; Nelson HS; Kemp J; Parasuraman B; Uryniak T; Liljas B
    Ann Allergy Asthma Immunol; 2003 Mar; 90(3):323-30. PubMed ID: 12669896
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Formoterol (OXIS) Turbuhaler as a rescue therapy compared with salbutamol pMDI plus spacer in patients with acute severe asthma.
    Boonsawat W; Charoenratanakul S; Pothirat C; Sawanyawisuth K; Seearamroongruang T; Bengtsson T; Brander R; Selroos O
    Respir Med; 2003 Sep; 97(9):1067-74. PubMed ID: 14509562
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Drug delivery to the lungs from dry powder inhalers.
    Newman SP
    Curr Opin Pulm Med; 2003 Apr; 9 Suppl 1():S17-20. PubMed ID: 12974538
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Early bronchodilatory effects of budesonide/formoterol pMDI compared with fluticasone/salmeterol DPI and albuterol pMDI: 2 randomized controlled trials in adults with persistent asthma previously treated with inhaled corticosteroids.
    Hampel FC; Martin P; Mezzanotte WS
    J Asthma; 2008 May; 45(4):265-72. PubMed ID: 18446589
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Once-daily budesonide inhalation powder (Pulmicort Turbuhaler) maintains pulmonary function and symptoms of asthmatic children previously receiving inhaled corticosteroids.
    Shapiro GG; Mendelson LM; Pearlman DS
    Ann Allergy Asthma Immunol; 2001 Jun; 86(6):633-40. PubMed ID: 11428735
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Dose-response relationship of inhaled budesonide in adult asthma: a meta-analysis.
    Masoli M; Holt S; Weatherall M; Beasley R
    Eur Respir J; 2004 Apr; 23(4):552-8. PubMed ID: 15083753
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Once-daily budesonide via Turbuhaler improves symptoms in adults with persistent asthma.
    Banov CH; Howland WC; Lumry WR
    Ann Allergy Asthma Immunol; 2001 Jun; 86(6):627-32. PubMed ID: 11428734
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.